Clinical trial
Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia
NCT02687581 is registered in ClinicalTrials.gov with Salus University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia
- Lead sponsor
- Salus University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 19, 2016
- Completion date
- May 30, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.